European Journal of Internal Medicine
Publisher: Elsevier · ISSN 0953-6205 · 84 articles
- Using latent class analysis for identifying clinical phenotypes associated with prognosis in patients with atrial high-rate episodes
- The time has come for comprehensive geriatric assessment in internal medicine
- Risk reclassification and implementation challenges in the 2026 AHA/ACC pulmonary embolism guideline
- Severe hyperkalaemia during liposomal amphotericin B treatment, independent of nephrotoxicity
- Interpreting diagnosis-specific hospitalisation after atrial fibrillation screening: Diagnostic attribution and time origin
- Logistic regression ignores time-to-event in competing risks analysis
- Baseline or dynamic prediction after venous thromboembolism? Clarifying the clinical use of the CAVE score for occult cancer
- Readmission risk after protected discharge: are multidimensional tools superior to functional scales?
- Considerations regarding the diagnosis of short telomere syndrome in a patient with opportunistic infections
- Circulating metabolites in adolescence associated with clinical obesity in young adulthood
- Bridging the gap between guidelines: ultrasound and the diagnostic continuum of venous thromboembolism
- Uro-gynecological disorders in women with non-celiac gluten/wheat sensitivity: a prospective study and response to a wheat-free diet
- Risk factors for recurrent venous thromboembolism in patients with active cancer in the direct oral anticoagulant era
- Editorial rejection and commercial journal recommendations
- Volume status of patients with hyponatremia across the age span – results from a large prospective international study
- Malnutrition in internal medicine wards: complementary evidence from the REPOSI and SIMI-NUTRO studies
- Interpreting uromodulin and sodium sensitivity in chronic kidney disease
- Nucleos(t)ide analogue discontinuation strategy to achieve the functional cure for chronic hepatitis B? A systematic review and meta-analysis
- Risk-stratified treatment of type 1 autoimmune pancreatitis: A narrative review positioning rituximab and inebilizumab
- Who benefits from exercise-based prehabilitation? Study-level moderators are not patient-level effect modifiers
- Assessment of eligibility for evidence-based pharmacological therapies in acute heart failure across heart failure with reduced and non-reduced ejection fraction
- Diuretic response in very elderly patients with acute heart failure. Author’s reply
- Glucagon-like peptide-1 receptor agonists in adults with overweight/obesity and alcohol use disorder: A retrospective cohort study
- Automated verification of citation support and reference accuracy: a pilot evaluation of CiteWell